01 1Bionpharma
01 1DAPAGLIFLOZIN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-05
Pay. Date : 2017-08-30
DMF Number : 32036
Submission : 2017-09-01
Status : Active
Type : II
20
Bionpharma Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DAPAGLIFLOZIN, with a corresponding US DMF Number 32036.
Remarkably, this DMF maintains an Active status since its submission on September 01, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 05, 2017, and payment made on August 30, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
